Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: 2A Biosciences, Inc.
February 10, 2026
2A Biosciences, Inc.
Orphan Drug Designation
treatment of neurotrophic keratopathy
Disease Area:
Rare Disease
Source
Source
Scroll to Top
